- •OAB women have more psychological distress, neuroticism, and introversion than non-OAB women.
- •Antimuscarinics could improve anxiety.
- •Antimuscarinics could improve global psychological distress.
To investigate the characteristics of psychological distress (PD), personality traits, and family support in women with overactive bladder syndrome (OAB), and the effects of antimuscarinic treatment.
Women with and without OAB (age- and body mass index [BMI]-matched control group) were prospectively enrolled; they recorded bladder diaries, underwent urodynamic studies, and completed PD, personality traits, and filled family support questionnaires before and after antimuscarinic treatment. OAB women underwent treatment with tolterodine or solifenacin for 12 weeks. The control group completed questionnaires.
Main outcome measures
The differences in PD, personality traits, and family support scores between both groups, and the changes after antimuscarinic treatment in OAB women.
Eighty-five women with OAB (tolterodine, n = 42; solifenacin, n = 43) and 65 without OAB completed the studies. Linear regression analysis with age and BMI adjustment revealed: coefficients of OAB were significant (all P < 0.05) for somatic complaints (mean: 0.87 vs. 0.63, coefficient = 0.21), obsessive–compulsive symptoms (0.69 vs. 0.44, coefficient = 0.25), anxiety symptoms (0.42 vs. 0.27, coefficient = 0.14), General Symptom Index (GSI, 0.48 vs. 0.33, coefficient = 0.14), neuroticism (9.23 vs. 5.17, coefficient = 3.73), and extroversion–introversion (13.64 vs. 15.25, coefficient = −1.73). Anxiety symptoms (0.42 vs. 0.36) and GSI (0.48 vs. 0.39) improved after antimuscarinics (all P < 0.05). High Overactive Bladder Symptom Score questionnaire score (coefficient = −0.39), low hostility score (coefficient = 2.11), and high additional symptoms score (coefficient = −1.46) were associated with good therapeutic effect (all P < 0.05).
OAB women experience more PD, neuroticism, and introversion than asymptomatic women, and antimuscarinics could improve PD.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Maturitas
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.Int Urogynecol J. 2010; 21: 5-26
- Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function.Lancet. 2001; 358: 401-403
- Psychiatric aspects of urinary incontinence in women attending an outpatient urodynamic clinic.BMJ. 1990; 301: 271-272
- Psychosexual study of women with detrusor instability.Obstet Gynecol. 1990; 75: 22-26
- Psychological investigation in female patients suffering from urinary incontinence.Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9: 73-77
- Urinary incontinence and depression.J Urol. 1999; 162: 82-84
- Anticholinergics for overactive bladder therapy: central nervous system effects.CNS Neurosci Ther. 2012; 18: 167-174
- Cognitive dysfunction with tolterodine use.Am J Obstet Gynecol. 2007; 197: e8
- Tolterodine and memory: dry but forgetful.Arch Neurol. 2003; 60: 771-773
- Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome.J Obstet Gynaecol Res. 2011; 37: 1084-1091
- Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.Eur Urol. 2013; 64: 74-81
- Symptom assessment tool for overactive bladder syndrome – Overactive Bladder Symptom Score.Urology. 2006; 68: 318-323
- Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.Neurourol Urodyn. 1995; 14: 131-139
- Sustained effectiveness of percutaneous tibial nerve stimulation for overactive bladder syndrome: 2-year follow-up of positive responders.Int Urogynecol J. 2013; 24: 795-799
- The Brief Symptom Inventory: an introductory report.Psychol Med. 1983; 13: 595-605
- Hyperleptinemia in subjects with persistent partial posttraumatic stress disorder after a major earthquake.Psychosom Med. 2004; 66: 23-28
- The Maudsley Personality Inventory as a prognostic instrument.Br J Psychiatry. 1970; 116: 21-26
- The Family APGAR Index: study on relationship between family function, social support, global stress and mental health perception in women.Int J Occup Med Environ Health. 1994; 7: 23-32
- Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in clinical practice.J Formos Med Assoc. 1990; 89: 1081-1087
- Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy.J Gastroenterol Hepatol. 2006; 21: 798-804
- Personality as an effective predictor of outcome of neurotic disorders.Chinese Psychiatry. 1990; 4 ([In Chinese]): 111-121
- Responsiveness and minimal clinically important change in Overactive Bladder Symptom Score.Urology. 2011; 78: 768-773
- Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.Urology. 2012; 80: 90-96
- Comparisons of pelvic floor muscle performance, anxiety, quality of life and life stress in women with dry overactive bladder compared with asymptomatic women.BJU Int. 2012; 109: 1685-1689
- Do colour and personality influence treatment seeking behaviour in women with lower urinary tract symptoms?. A prospective study using the short Luscher colour test.J Obstet Gynaecol. 2009; 29: 407-411
- Association between severity of schizophrenic symptoms and urinary retention.Eur Psychiatry. 2001; 16: 497-500
- We have to stop again?!: The impact of overactive bladder on family members.Neurourol Urodyn. 2009; 28: 969-975
- Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months.Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20: 381-385
- Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.J Am Geriatr Soc. 2011; 59: 501-505
- Response to treatment of detrusor instability in relation to psychoneurotic status.Br J Urol. 1990; 66: 486-490
- Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment.BJU Int. 2011; 108: 1834-1838
- Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience.BJU Int. 2012; 110: 1767-1774
Published online: September 03, 2014
Accepted: August 14, 2014
Received in revised form: August 9, 2014
Received: May 21, 2014
© 2014 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.